KLIPING BERITA HIV & AIDS
Jenis HIV Kebal Obat Makin Meningkat di Negara Miskin
24 Juli 2012  10:43:01 WIB
Hasil kesimpulan dari data 26.102 pasien sejak tahun 2001 hingga 2011. Di beberapa negara berkembang, jenis HIV yang kebal terhadap obat-obatan kian berkembang, terutama di bagian timur dan selatan Afrika, begitu hasil laporan studi terkini yang dilansir jurnal kesehatan The Lancet. Hal ini bisa membahayakan keefektivitasan program perawatan HIV nasional, kata studi tersebut. Resistensi terhadap perawatan bisa mengakibatkan pasien untuk tidak menjalani aturan ketat dalam mengkonsumsi obat antiretroviralnya. Kesimpulan ini merupakan hasil studi yang dilangsungkan… more
Saat Menentukan dalam Penanganan AIDS
24 Juli 2012  10:37:05 WIB
Konferensi AIDS di Washington diharapkan menandai titik balik dalam upaya memerangi virus mematikan Dr. Diane Havlir optimis: "Untuk pertama kalinya saya merasa bahwa kita berada pada awal dari akhir epidemi AIDS." Havlir adalah dokter di RS San Francisco General Hospital dan merupakan salah satu ketua dari Konferensi Internasional AIDS yang digelar dari tanggal 22 hingga 27 Juli di Washington, ibukota Amerika Serikat. Simbol test darah HIV AIDS Dengan rekan-rekannya ia hendak "bersama-sama membuka halaman baru",… more
HIV/AIDS and the Public Health Crisis in Our Communities: The Time for Action Is Now
24 Juli 2012  08:32:13 WIB
At this year's International AIDS Conference in Washington, D.C. (July 22-27), leaders and experts from around the globe will gather to strategize about ending the HIV/AIDS epidemic. I'm looking forward to participating in events and panel discussions that highlight the progress we've made and the challenges we still face nationally and internationally. But the reality is, we need to do more than talk. Community-based action is vital. Ironically, our leaders would do well to mirror… more
HIV jab could soon replace daily pill regimen
24 Juli 2012  08:21:35 WIB
Researchers are trying to develop an injection that will replace the daily pill regimen for HIV patients. Earlier this week, the Food and Drug Administration approved a daily pill, Truvada, which reduces the risk of HIV infection. A team of researchers from the University of Nebraska Medical Center is progressing towards developing weekly or twice-monthly injectable antiretroviral therapy (ART) nanomedicines for patients with human immunodeficiency virus (HIV) infection. A long-acting, nanoformulated ART (nanoART) would be… more
HIV prevention done right
24 Juli 2012  08:17:39 WIB
This week, tens of thousands of delegates are meeting in Washington for the biennial International AIDS Conference, striving to advance an agenda for an AIDS-free generation. Achieving such an ambitious goal will require multiple strategies, but virtually all agree that male circumcision — which provides powerful protection against HIV infection as well as other health benefits for men and women — must be a core element. Yet although some prevention efforts in Africa have been… more